NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.

MLA

Rosa-Rosa, Juan Manuel, et al. “NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.” Cancers, vol. 14, no. 20, Oct. 2022. EBSCOhost, https://doi.org/10.3390/cancers14205169.

APA

Rosa-Rosa, J. M., Cuenca, I., Medina, A., Vázquez, I., Sánchez-delaCruz, A., Buenache, N., Sánchez, R., Jiménez, C., Rosiñol, L., Gutiérrez, N. C., Ruiz-Heredia, Y., Barrio, S., Oriol, A., Martin-Ramos, M.-L., Blanchard, M.-J., Ayala, R., Ríos-Tamayo, R., Sureda, A., Hernández, M.-T., … Martínez-Lopez, J. (2022). NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. Cancers, 14(20). https://doi.org/10.3390/cancers14205169

Chicago

Rosa-Rosa, Juan Manuel, Isabel Cuenca, Alejandro Medina, Iria Vázquez, Andrea Sánchez-delaCruz, Natalia Buenache, Ricardo Sánchez, et al. 2022. “NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.” Cancers 14 (20). doi:10.3390/cancers14205169.